Receive our newsletter – data, insights and analysis delivered to you
  1. Dashboards
  2. Jobs
March 31, 2021updated 20 May 2021 5:22pm

Medtech jobs weekly snapshot: Amy Abernathy steps down from FDA after two years

From 21 March to 26 March 2021, 12,839 medtech jobs were posted worldwide. The US Food and Drug Administration (FDA) made headlines when its chief information officer and second-in-command Amy Abernathy stepped down from her role after two years.

By Chloe Kent

In the week of 21 March to 26 March, 12,839 medtech jobs were posted worldwide by 332 companies, according to the GlobalData jobs analytics tool.

Bausch & Lomb was once again the most prolific hirer across the medtech industry, posting 1,304 jobs. It was followed by PPD Group, which made 856 listings, and Sonova Holding, which advertised for 738 positions.

Bausch & Lomb parent company Bausch Health completed the sale of is Egyptian drug unit Amoun Pharmaceutical to Abu Dhabi’s sovereign wealth fund ADQ for $740m this week, ahead of the planned separation of Bausch & Lomb from the rest of the organisation.

Bausch Health CEO Joseph Papa said: “The sale of Amoun marks significant progress in our efforts to reduce overall Bausch Health debt as we continue to pursue all opportunities to drive value for our shareholders, including preparing for the spinoff of Bausch & Lomb.”

FDA second-in-command steps down after two years

The US Food and Drug Administration has made headlines in the past week, following the resignation of its chief information officer and second-in-command Amy Abernathy. Abernathy, who oversaw tech and data modernisation at the FDA and has thus worked closely with parts of the medtech industry, is stepping down after only two years in the role.

Abernathy also launched the FDA’s Covid-19 accelerator project to boost real-world data gathering.

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

Her departure comes as pressure mounts on President Joe Biden to appoint a permanent FDA head, two months into his administration. Abernathy was at one point considered a contender for the role.

In a series of tweets, Abernathy emphasised the importance of rethinking US digital health infrastructure, and noted that she was going to spend some time off with her family and would be “back at it soon”.

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy